BCHE and early-onset autosomal dominant Alzheimer disease: Additionally, Magnofluorine was tested against some metabolic enzymes, including acetylcholinesterase, α-glycosidase, butyrylcholinesterase, and carbonic anhydrase isoform II, which are linked to some common and global diseases, such as epilepsy, diabetes, Alzheimer’s disease, and glaucoma.